Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

NASA Science Data Powers New Method to Discover Hard-to-Find Pulsars

An international team of scientists has developed a method that can find pulsars in publicly available NASA data about a million times faster than before. This opens the door to discovering many more of these rapidly spinning objects. A paper describing the results published Thursday in the Physical Review Letters.

Using 15 years of data from NASA’s Fermi Gamma-ray Space Telescope and a cryptography-based method developed by study co-authors Dotan Gazith and Barak Zackay from the Weizmann Institute of Science in Israel, the team found PSR J1622−7204, an isolated pulsar spinning 261 times per second, using the equivalent of 10 hours of computing time on a standard computer processor.

By comparison, the previous best method failed to find the pulsar, despite using enough computing power that a standard processor would take 600 years to perform the calculation.

I Think Only a Mythical Demon Could Perfectly Predict You

Astrophysicist Matt O’Dowd, host of PBS Space Time, argues that free will is real in a meaningful sense. In his view, the no-cloning theorem stops any possible observer from perfectly predicting your choices, and only Laplace’s demon, a mythical being, could. #FreeWill #Physics #Quantum Full Podcast with Matt O’Dowd: https://youtu.be/T6xLFRHW-IY …

Abstract: See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer

See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer.

Address for correspondence. Hongpeng Jia, Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, 1721 E. Madison Street, Baltimore, Maryland, 21,208, USA. Email: [email protected].

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and allowing those genes to switch back on.

Understanding how azacitidine works matters because the drug helps only a third to half of patients, and doctors have no reliable way to predict who will benefit.

In a recent study published in Molecular Cell, researchers at the University of Chicago and UT Health San Antonio report that during the first day of treatment, when the drug kills the most cancer cells, almost none of it happens in DNA, but instead mostly in RNA. There, it strips chemical tags from RNA and shuts down genes that cancer cells need to divide and repair their DNA. The research findings point to NSUN2, the enzyme that installs those tags, as a more precise drug target.

Dual-purpose polymer dots could combine bioimaging and light-triggered cell death in one material

A research team led by professor Youhei Takeda at the University of Osaka, in collaboration with professor Zachary M. Hudson at the University of British Columbia (UBC) in Canada, has developed a polymer material that combines fluorescent cell imaging with the potential to kill cancer cells when activated by light. The material could offer a simpler approach to developing “nanotheranostic” technologies, which bring disease imaging and treatment together in a single platform.

Nanotheranostic materials are challenging to develop because one material must accommodate the different demands of both imaging and therapy.

Immortalism, Deathism, Healthspan, and Survival

This intense and stimulating discussion between Kai Micah Mills, Aubrey de Grey, and Max More begins by investigating claims made by Kai at his Vitalist Bay talk. In particular, his claim that there is a retreat from immortalism and hardcore life extension advocacy. Max and Aubrey agree and disagree with elements of his claim. We discuss the immortalism in Russian Cosmism, the similarities in the thought of Frank Tipler and Mormon church, and raise the possibility that past people do not want to be resurrected. Also discussed:

Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s

Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among those under 50, MPs have heard.

Cases of early-onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.

Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can explain only about half of the cases doctors diagnose.

Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex

Psilocybin is a serotonergic psychedelic believed to have therapeutic potential for neuropsychiatric conditions. Despite well-documented prevalence of perceptual alterations, hallucinations, and synesthesia associated with psychedelic experiences, little is known about how psilocybin affects sensory cortex or alters the activity of neurons in awake animals. To investigate, we conducted two-photon imaging experiments in auditory cortex of awake mice and collected video of free-roaming mouse behavior, both at baseline and during psilocybin treatment. In comparison with pre-dose neural activity, a 2 mg/kg ip dose of psilocybin initially increased the amplitude of neural responses to sound. Thirty minutes post-dose, behavioral activity and neural response amplitudes decreased, yet functional connectivity increased. In contrast, control mice given intraperitoneal saline injections showed no significant changes in either neural or behavioral activity across conditions. Notably, neuronal stimulus selectivity remained stable during psilocybin treatment, for both tonotopic cortical maps and single-cell pure-tone frequency tuning curves. Our results mirror similar findings regarding the effects of serotonergic psychedelics in visual cortex and suggest that psilocybin modulates the balance of intrinsic versus stimulus-driven influences on neural activity in auditory cortex.

NEW & NOTEWORTHY Recent studies have shown promising therapeutic potential for psychedelics in treating neuropsychiatric conditions. Musical experience during psilocybin-assisted therapy is predictive of treatment outcome, yet little is known about how psilocybin affects auditory processing. Here, we conducted two-photon imaging experiments in auditory cortex of awake mice that received a dose of psilocybin. Our results suggest that psilocybin modulates the roles of intrinsic neural activity versus stimulus-driven influences on auditory perception.